Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates
Open Access
- 1 January 2020
- journal article
- review article
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 5, 10
Abstract
The incidence of non-alcoholic fatty liver disease (NAFLD) is rapidly growing, affecting 25% of the world population. Non-alcoholic steatohepatitis (NASH) is the most severe form of NAFLD and affects 1.5% to 6.5% of the world population. Its rising incidence will make end-stage liver disease (ESLD) due to NASH the number one indication for liver transplantation (LT) in the next 10 to 20 years, overtaking Hepatitis C. Patients with NASH also have a high prevalence of associated comorbidities such as type 2 diabetes, obesity, metabolic syndrome, cardiovascular disease, and chronic kidney disease (CKD), which must be adequately managed during the peritransplant period for optimal post-transplant outcomes. The focus of this review article is to provide a comprehensive overview of the unique challenges these patients present in the peritransplant period, which comprises the pre-transplant, intraoperative, and immediate postoperative periods.Keywords
This publication has 100 references indexed in Scilit:
- Comparable graft and patient survival in lean and obese liver transplant recipientsLiver Transplantation, 2013
- Liver transplantation: Advances and perioperative careIndian Journal of Anaesthesia, 2012
- Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trialHepatology, 2011
- Glycemic Control by A Glucose Management Service and Infection Rates After Liver TransplantationEndocrine Practice, 2011
- The Influence of Nonalcoholic Fatty Liver Disease and Its Associated Comorbidities on Liver Transplant OutcomesJournal of Clinical Gastroenterology, 2011
- Relationship between Kidney Function and Liver Histology in Subjects with Nonalcoholic SteatohepatitisClinical Journal of the American Society of Nephrology, 2010
- Sarcopenia: European consensus on definition and diagnosisAge and Ageing, 2010
- Posttransplant Hyperglycemia is Associated With Increased Risk of Liver Allograft RejectionTransplantation, 2010
- Nonalcoholic Fatty Liver Disease as a Contributor to Hypercoagulation and Thrombophilia in the Metabolic SyndromeSeminars in Thrombosis and Hemostasis, 2009
- Prolonged Waiting Times for Liver Transplantation in Obese PatientsAnnals of Surgery, 2008